Corrigendum to “The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate” [Experimental Neurology 233/1 (2012) 472–480]

Transplantation of mesenchymal stem cells in ALS

“…It is unclear whether these data may significantly affect the efficacy and the outcome of the treatment. Some recent studies (Koh et al, 2012), however, show that a reduction in the pluripotency and capacity to secrete trophic factors of the BM-MSCs of ALS patients correlates with poorer prognosis.…”